LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 63

Search options

  1. Article ; Online: Systematic reanalysis of genomic data by diagnostic laboratories: a scoping review of ethical, economic, legal and (psycho)social implications.

    van der Geest, Marije A / Maeckelberghe, Els L M / van Gijn, Marielle E / Lucassen, Anneke M / Swertz, Morris A / van Langen, Irene M / Plantinga, Mirjam

    European journal of human genetics : EJHG

    2024  Volume 32, Issue 5, Page(s) 489–497

    Abstract: With the introduction of Next Generation Sequencing (NGS) techniques increasing numbers of disease-associated variants are being identified. This ongoing progress might lead to diagnoses in formerly undiagnosed patients and novel insights in already ... ...

    Abstract With the introduction of Next Generation Sequencing (NGS) techniques increasing numbers of disease-associated variants are being identified. This ongoing progress might lead to diagnoses in formerly undiagnosed patients and novel insights in already solved cases. Therefore, many studies suggest introducing systematic reanalysis of NGS data in routine diagnostics. Introduction will, however, also have ethical, economic, legal and (psycho)social (ELSI) implications that Genetic Health Professionals (GHPs) from laboratories should consider before possible implementation of systematic reanalysis. To get a first impression we performed a scoping literature review. Our findings show that for the vast majority of included articles ELSI aspects were not mentioned as such. However, often these issues were raised implicitly. In total, we identified nine ELSI aspects, such as (perceived) professional responsibilities, implications for consent and cost-effectiveness. The identified ELSI aspects brought forward necessary trade-offs for GHPs to consciously take into account when considering responsible implementation of systematic reanalysis of NGS data in routine diagnostics, balancing the various strains on their laboratories and personnel while creating optimal results for new and former patients. Some important aspects are not well explored yet. For example, our study shows GHPs see the values of systematic reanalysis but also experience barriers, often mentioned as being practical or financial only, but in fact also being ethical or psychosocial. Engagement of these GHPs in further research on ELSI aspects is important for sustainable implementation.
    MeSH term(s) Humans ; Genetic Testing/ethics ; Genetic Testing/economics ; Genetic Testing/legislation & jurisprudence ; Genetic Testing/standards ; Genetic Testing/methods ; High-Throughput Nucleotide Sequencing/ethics ; Genomics/ethics ; Genomics/legislation & jurisprudence ; Genomics/methods ; Laboratories, Clinical
    Language English
    Publishing date 2024-03-14
    Publishing country England
    Document type Journal Article ; Review ; Research Support, Non-U.S. Gov't
    ZDB-ID 1141470-4
    ISSN 1476-5438 ; 1018-4813
    ISSN (online) 1476-5438
    ISSN 1018-4813
    DOI 10.1038/s41431-023-01529-z
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: [No title information]

    Cuperus, Edwin / Sigurdsson, Vigfús / van den Akker, Peter C / Bolling, Marieke C / van Gijn, Mariëlle E / Pasmans, Suzanne G M A

    Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG

    2021  Volume 19, Issue 4, Page(s) 611–614

    Title translation Diagnostisches Next Generation Sequencing bei neonataler Erythrodermie.
    Language German
    Publishing date 2021-04-16
    Publishing country Germany
    Document type Letter
    ZDB-ID 2093479-8
    ISSN 1610-0387 ; 1610-0379
    ISSN (online) 1610-0387
    ISSN 1610-0379
    DOI 10.1111/ddg.14298_g
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Diagnostic next generation sequencing in neonatal erythroderma.

    Cuperus, Edwin / Sigurdsson, Vigfús / van den Akker, Peter C / Bolling, Marieke C / van Gijn, Mariëlle E / Pasmans, Suzanne G M A

    Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG

    2020  Volume 19, Issue 4, Page(s) 612–614

    MeSH term(s) Dermatitis, Exfoliative/diagnosis ; Dermatitis, Exfoliative/genetics ; High-Throughput Nucleotide Sequencing ; Humans ; Infant, Newborn
    Language English
    Publishing date 2020-10-26
    Publishing country Germany
    Document type Letter ; Research Support, Non-U.S. Gov't
    ZDB-ID 2093479-8
    ISSN 1610-0387 ; 1610-0379
    ISSN (online) 1610-0387
    ISSN 1610-0379
    DOI 10.1111/ddg.14298
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Dysregulation of miRNA-30e-3p targeting IL-1β in an international cohort of systemic autoinflammatory disease patients.

    Akbaba, Tayfun Hilmi / Akkaya-Ulum, Yeliz Z / Batu, Ezgi Deniz / Penco, Federica / Wittkowski, Helmut / Kant, Benjamin / van Gijn, Marielle E / Foell, Dirk / Gattorno, Marco / Ozen, Seza / Balci-Peynircioglu, Banu

    Journal of molecular medicine (Berlin, Germany)

    2023  Volume 101, Issue 6, Page(s) 757–766

    Abstract: Autoinflammation is the standard mechanism seen in systemic autoinflammatory disease (SAID) patients. This study aimed to investigate the effect of a candidate miRNA, miR-30e-3p, which was identified in our previous study, on the autoinflammation ... ...

    Abstract Autoinflammation is the standard mechanism seen in systemic autoinflammatory disease (SAID) patients. This study aimed to investigate the effect of a candidate miRNA, miR-30e-3p, which was identified in our previous study, on the autoinflammation phenotype seen in SAID patients and to analyze its expression in a larger group of European SAID patients. We examined the potential anti-inflammatory effect of miR-30e-3p, which we had defined as one of the differentially expressed miRNAs in microarray analysis involved in inflammation-related pathways. This study validated our previous microarray results of miR-30e-3p in a cohort involving European SAID patients. We performed cell culture transfection assays for miR-30e-3p. Then, in transfected cells, we analyzed expression levels of pro-inflammatory genes; IL-1β, TNF-α, TGF-β, and MEFV. We also performed functional experiments, caspase-1 activation by fluorometric assay kit, apoptosis assay by flow cytometry, and cell migration assays by wound healing and filter system to understand the possible effect of miR-30e-3p on inflammation. Following these functional assays, 3'UTR luciferase activity assay and western blotting were carried out to identify the target gene of the aforementioned miRNA. MiR-30e-3p was decreased in severe European SAID patients like the Turkish patients. The functional assays associated with inflammation suggested that miR-30e-3p has an anti-inflammatory effect. 3'UTR luciferase activity assay demonstrated that miR-30e-3p directly binds to interleukin-1-beta (IL-1β), one of the critical molecules of inflammatory pathways, and reduces both RNA and protein levels of IL-1β. miR-30e-3p, which has been associated with IL-1β, a principal component of inflammation, might be of potential diagnostic and therapeutic value for SAIDs. KEY MESSAGES: miR-30e-3p, which targets IL-1β, could have a role in the pathogenesis of SAID patients. miR-30e-3p has a role in regulating inflammatory pathways like migration, caspase-1 activation. miR-30e-3p has the potential to be used for future diagnostic and therapeutic approaches.
    MeSH term(s) Humans ; MicroRNAs/genetics ; MicroRNAs/metabolism ; 3' Untranslated Regions ; Inflammation/genetics ; Hereditary Autoinflammatory Diseases/genetics ; Anti-Inflammatory Agents ; Luciferases/genetics ; Caspases ; Interleukin-1beta/metabolism ; Pyrin/genetics
    Chemical Substances MicroRNAs ; 3' Untranslated Regions ; Anti-Inflammatory Agents ; Luciferases (EC 1.13.12.-) ; Caspases (EC 3.4.22.-) ; Interleukin-1beta ; MEFV protein, human ; Pyrin
    Language English
    Publishing date 2023-05-22
    Publishing country Germany
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1223802-8
    ISSN 1432-1440 ; 0946-2716
    ISSN (online) 1432-1440
    ISSN 0946-2716
    DOI 10.1007/s00109-023-02327-2
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Cost and impact of early diagnosis in primary immunodeficiency disease: A literature review.

    Elsink, Kim / van Montfrans, Joris M / van Gijn, Mariëlle E / Blom, Maartje / van Hagen, P Martin / Kuijpers, T W / Frederix, Geert W J

    Clinical immunology (Orlando, Fla.)

    2020  Volume 213, Page(s) 108359

    Abstract: Background: New, innovative, costly diagnostic methods for patients with primary immunodeficiencies (PID) demand upfront insight into their potential cost savings and added value for individual patients. As such, high quality, comparable economic ... ...

    Abstract Background: New, innovative, costly diagnostic methods for patients with primary immunodeficiencies (PID) demand upfront insight into their potential cost savings and added value for individual patients. As such, high quality, comparable economic evaluations are of utmost importance to enable informed decisions. The objective of this review was therefore to create an extensive overview of current costing studies and potential cost savings of early diagnosis in primary immunodeficiency disease.
    Methods: A literature search in PubMed was conducted and studies involving any form of costing study in the field of PIDs were included. Of the included studies, study characteristics, cost parameters and benefits of early diagnosis were extracted and outlined in separate tables.
    Results: Twenty two studies met the inclusion criteria and were included in the review. The papers were categorized according to their subject: neonatal screening for severe combined immunodeficiency (SCID), Ig replacement therapies and studies reporting on costs of general or specific PIDs. Within and between these groups variability in reported costing characteristics was observed. In studies that reported cost savings pre- and post-diagnosis, cost savings ranged from 6500 to 108,463 USD of total costs per patient.
    Conclusion: This literature review shows that, regardless of what aspect of PIDs has been studied, in nearly all cases early diagnosis reduces health care consumption and leads to better health outcomes for patients with PIDs. We found considerable variability in costing characteristics of economic evaluations of PID patients, which hampers the comparability of outcomes. More effort is needed to create uniformity and define cost parameters in economic evaluations in the field of PIDs, facilitating further prospective research to extensively assess the benefits of early diagnosis.
    MeSH term(s) Cost-Benefit Analysis ; Early Diagnosis ; Humans ; Primary Immunodeficiency Diseases/diagnosis ; Primary Immunodeficiency Diseases/economics
    Language English
    Publishing date 2020-02-05
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 1459903-x
    ISSN 1521-7035 ; 1521-6616
    ISSN (online) 1521-7035
    ISSN 1521-6616
    DOI 10.1016/j.clim.2020.108359
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Enhanced hepatic clearance of hyposialylated platelets explains thrombocytopenia in GNE-related macrothrombocytopenia.

    Noordermeer, Tessa / van Asten, Ivar / Schutgens, Roger E G / Lakerveld, Anke J / Koekman, Cornelis A / Hage, Kay Y / Sebastian, Silvie A E / Huisman, Albert / van den Heuvel, Dave J / Gerritsen, Hans C / Korporaal, Suzanne J A / Bierings, Marc / van der Smagt, Jasper J / van Gijn, Mariëlle E / Urbanus, Rolf T

    Blood advances

    2022  Volume 6, Issue 11, Page(s) 3347–3351

    MeSH term(s) Anemia ; Blood Platelets ; Humans ; Platelet Count ; Thrombocytopenia
    Language English
    Publishing date 2022-03-07
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2915908-8
    ISSN 2473-9537 ; 2473-9529
    ISSN (online) 2473-9537
    ISSN 2473-9529
    DOI 10.1182/bloodadvances.2021006830
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Clinical Symptoms, Laboratory Parameters and Long-Term Follow-up in a National DADA2 Cohort.

    Andriessen, Marie Valérie E / Legger, G Elizabeth / Bredius, Robbert G M / van Gijn, Marielle E / Hak, A Elisabeth / Muller, Petra C E Hissink / Kamphuis, Sylvia / Klouwer, Femke C C / Kuijpers, Taco W / Leavis, Helen L / Nierkens, Stefan / Rutgers, Abraham / van der Veken, Lars T / van Well, Gijs T J / Mulders-Manders, Catharina M / van Montfrans, Joris M

    Journal of clinical immunology

    2023  Volume 43, Issue 7, Page(s) 1581–1596

    Abstract: Deficiency of adenosine deaminase-2 (DADA2) is an autosomal recessive autoinflammatory disease with an extremely variable disease presentation. This paper provides a comprehensive overview of the Dutch DADA2 cohort. We performed a retrospective cohort ... ...

    Abstract Deficiency of adenosine deaminase-2 (DADA2) is an autosomal recessive autoinflammatory disease with an extremely variable disease presentation. This paper provides a comprehensive overview of the Dutch DADA2 cohort. We performed a retrospective cohort study in 29 ADA2-deficient patients from 23 families with a median age at inclusion of 26 years. All patients had biallelic pathogenic variants in the ADA2 gene. The most common clinical findings included cutaneous involvement (79.3%), (hepato)splenomegaly (70.8%) and recurrent infections (58.6%). Stroke was observed in 41.4% of the patients. The main laboratory abnormalities were hypogammaglobulinemia and various cytopenias. Patients presented most often with a mixed phenotype involving vasculopathy, immunodeficiency and hematologic manifestations (62.1%). In this cohort, malignancies were reported in eight patients (27.6%), of whom five presented with a hematologic malignancy and two with a basal cell carcinoma. Four patients developed hemophagocytic lymphohistiocytosis (HLH) or an HLH-like episode, of whom three passed away during or shortly after the occurrence of HLH. TNF-inhibitors (TNFi) were effective in treating vasculopathy-associated symptoms and preventing stroke, but were hardly effective in the treatment of hematologic manifestations. Three patients underwent hematopoietic cell transplantation and two of them are doing well with complete resolution of DADA2-related symptoms. The overall mortality in this cohort was 17.2%. In conclusion, this cohort describes the clinical, genetic and laboratory findings of 29 Dutch DADA2 patients. We describe the occurrence of HLH as a life-threatening disease complication and report a relatively high incidence of malignancies and mortality.
    MeSH term(s) Humans ; Adult ; Adenosine Deaminase/genetics ; Follow-Up Studies ; Retrospective Studies ; Intercellular Signaling Peptides and Proteins/genetics ; Stroke ; Lymphohistiocytosis, Hemophagocytic ; Mutation/genetics
    Chemical Substances Adenosine Deaminase (EC 3.5.4.4) ; Intercellular Signaling Peptides and Proteins
    Language English
    Publishing date 2023-06-05
    Publishing country Netherlands
    Document type Review ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 779361-3
    ISSN 1573-2592 ; 0271-9142
    ISSN (online) 1573-2592
    ISSN 0271-9142
    DOI 10.1007/s10875-023-01521-8
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: AI-Inclusivity in Healthcare: Motivating an Institutional Epistemic Trust Perspective.

    Maheshwari, Kritika / Jedan, Christoph / Christiaans, Imke / van Gijn, Mariëlle / Maeckelberghe, Els / Plantinga, Mirjam

    Cambridge quarterly of healthcare ethics : CQ : the international journal of healthcare ethics committees

    2024  , Page(s) 1–15

    Abstract: This paper motivates institutional epistemic trust as an important ethical consideration informing the responsible development and implementation of artificial intelligence (AI) technologies (or AI-inclusivity) in healthcare. Drawing on recent literature ...

    Abstract This paper motivates institutional epistemic trust as an important ethical consideration informing the responsible development and implementation of artificial intelligence (AI) technologies (or AI-inclusivity) in healthcare. Drawing on recent literature on epistemic trust and public trust in science, we start by examining the conditions under which we can have institutional epistemic trust in AI-inclusive healthcare systems and their members as providers of medical information and advice. In particular, we discuss that institutional epistemic trust in AI-inclusive healthcare depends, in part, on the reliability of AI-inclusive medical practices and programs, its knowledge and understanding among different stakeholders involved, its effect on epistemic and communicative duties and burdens on medical professionals and, finally, its interaction and alignment with the public's ethical values and interests as well as background sociopolitical conditions against which AI-inclusive healthcare systems are embedded. To assess the applicability of these conditions, we explore a recent proposal for AI-inclusivity within the Dutch Newborn Screening Program. In doing so, we illustrate the importance, scope, and potential challenges of fostering and maintaining institutional epistemic trust in a context where generating, assessing, and providing reliable and timely screening results for genetic risk is of high priority. Finally, to motivate the general relevance of our discussion and case study, we end with suggestions for strategies, interventions, and measures for AI-inclusivity in healthcare more widely.
    Language English
    Publishing date 2024-04-29
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1146581-5
    ISSN 1469-2147 ; 0963-1801
    ISSN (online) 1469-2147
    ISSN 0963-1801
    DOI 10.1017/S0963180124000215
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Collodion babies: A 15-year retrospective multicenter study in The Netherlands-Evaluation of severity scores to predict the underlying disease.

    Cuperus, Edwin / Bolling, Marieke C / de Graaf, Marlies / van den Akker, Peter C / van Gijn, Marielle E / Simon, Marleen E H / Sigurdsson, Vigfús / Pasmans, Suzanne G M A

    Journal of the American Academy of Dermatology

    2020  Volume 84, Issue 4, Page(s) 1111–1113

    MeSH term(s) Humans ; Ichthyosiform Erythroderma, Congenital/classification ; Ichthyosiform Erythroderma, Congenital/diagnosis ; Ichthyosiform Erythroderma, Congenital/genetics ; Netherlands ; Phenotype ; Retrospective Studies ; Severity of Illness Index
    Language English
    Publishing date 2020-06-12
    Publishing country United States
    Document type Journal Article ; Multicenter Study
    ZDB-ID 603641-7
    ISSN 1097-6787 ; 0190-9622
    ISSN (online) 1097-6787
    ISSN 0190-9622
    DOI 10.1016/j.jaad.2020.06.021
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Feasibility of predicting allele specific expression from DNA sequencing using machine learning.

    Zhang, Zhenhua / van Dijk, Freerk / de Klein, Niek / van Gijn, Mariëlle E / Franke, Lude H / Sinke, Richard J / Swertz, Morris A / van der Velde, K Joeri

    Scientific reports

    2021  Volume 11, Issue 1, Page(s) 10606

    Abstract: Allele specific expression (ASE) concerns divergent expression quantity of alternative alleles and is measured by RNA sequencing. Multiple studies show that ASE plays a role in hereditary diseases by modulating penetrance or phenotype severity. However, ... ...

    Abstract Allele specific expression (ASE) concerns divergent expression quantity of alternative alleles and is measured by RNA sequencing. Multiple studies show that ASE plays a role in hereditary diseases by modulating penetrance or phenotype severity. However, genome diagnostics is based on DNA sequencing and therefore neglects gene expression regulation such as ASE. To take advantage of ASE in absence of RNA sequencing, it must be predicted using only DNA variation. We have constructed ASE models from BIOS (n = 3432) and GTEx (n = 369) that predict ASE using DNA features. These models are highly reproducible and comprise many different feature types, highlighting the complex regulation that underlies ASE. We applied the BIOS-trained model to population variants in three genes in which ASE plays a clinically relevant role: BRCA2, RET and NF1. This resulted in predicted ASE effects for 27 variants, of which 10 were known pathogenic variants. We demonstrated that ASE can be predicted from DNA features using machine learning. Future efforts may improve sensitivity and translate these models into a new type of genome diagnostic tool that prioritizes candidate pathogenic variants or regulators thereof for follow-up validation by RNA sequencing. All used code and machine learning models are available at GitHub and Zenodo.
    MeSH term(s) Alleles ; Bias ; Feasibility Studies ; Gene Expression Regulation ; Genome, Human ; Humans ; Machine Learning ; Models, Genetic ; Polymorphism, Single Nucleotide/genetics ; ROC Curve ; Sequence Analysis, DNA
    Language English
    Publishing date 2021-05-19
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2615211-3
    ISSN 2045-2322 ; 2045-2322
    ISSN (online) 2045-2322
    ISSN 2045-2322
    DOI 10.1038/s41598-021-89904-y
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top